--- Chain 6 for Question 88 ---
Status: USED_FOR_VOTING
Finish Reason (Model): stop
Extracted Answer: A
Prompt Tokens (Usage): 168
Completion Tokens (Usage): 1044
Reasoning Tokens (Counted): 717
Non-Reasoning Tokens (Counted): 325
Total Tokens (Usage): 1212

--- Reasoning Content ---
Okay, so I've got this question about immunology, specifically about rotavirus and the immune response in mice. Hmm, let me try to break this down step by step.

The question says that inner capsid proteins of rotavirus are tagged with GFP and given to mice orally. Then, when they do in vivo imaging, some fluorescence is destroyed by stomach acid and some get entangled in intestinal mucus before reaching secondary lymphoid organs. They then look at the Peyer's patches and isolate the proliferating cells. When they sequence the variable heavy chain genes, they see high variability. What's happening here?

Wait, so Peyer's patches are part of the gut-associated lymphoid tissue (GALT). They're specialized for sampling antigens from the intestinal lumen. So when the rotavirus is given orally, the antigens would be presented to these patches.

The GFP-tagged proteins probably serve as antigens. In the stomach, acid could break down some of these, so not all make it past. Some get stuck in mucus, maybe not reaching the secondary lymphoid organs, but Peyer's patches are still in the intestinal area, so maybe that's where the immune response is initiated.

When they isolate the proliferating cells from the Peyer's patches, these are likely B cells that have been activated by the antigen. The sequencing shows high variability in the variable heavy chain genes. I remember that B cells undergo a process where their variable regions are diversified to create a wide range of antibodies.

Now, let's think about the processes listed in the options:

A) Somatic hypermutation: This occurs in B cells after they've been activated. It's a process where mutations are introduced into the variable regions of the B cell receptor (BCR) genes, increasing the diversity of antibodies. This happens during the later stages of the immune response, especially in the germinal centers.

B) Complement activation: That's part of the innate immune system, helps in opsonization and lytic activity of pathogens, but I don't think this directly causes variability in B cell receptors.

C) Class switching recombination: This is when the B cell changes the class of antibody it produces (like from IgM to IgG), but it doesn't directly increase the variability in the variable regions. It's more about the effector function.

D) VDJ recombination: That's the process during B cell development in the bone marrow where the variable (V), diversity (D), and joining (J) segments are combined to create the initial diversity of the B cell receptors. But this happens early on, during the maturation of B cells, so maybe not what's happening here.

Wait, but the question is about processes happening after the B cells have been activated and are proliferating. So when they're in the germinal centers, they undergo somatic hypermutation, which increases the variability of their receptors. This would explain the high variability in the variable regions they're seeing in the sequencing.

So the process here must be somatic hypermutation. The B cells are diversifying their antibodies to better recognize the rotavirus antigen, which in this case is the GFP-tagged capsid proteins.

Other options: VDJ is during initial B cell development, so not this. Class switching is about changing the isotype, not variable regions. Complement activation is more about innate and maybe phagocytosis or clearing pathogens, not directly about B cell receptor variability.

Therefore, the answer should be A) somatic hypermutation.


--- Final Answer Content ---


The question involves analyzing the immune response to GFP-tagged rotavirus inner capsid proteins administered to mice via oral gavage. The GFP-tagged proteins act as antigens, and some reach the Peyer's patches, where B cells are activated and proliferate. Sequencing the variable heavy chain genes of these proliferating cells reveals high variability, which suggests a process that diversifies the B cell receptors.

To evaluate the options:

- **A) Somatic hypermutation**: This process occurs in activated B cells during the immune response, particularly in germinal centers. It introduces mutations into the variable regions of B cell receptor genes, increasing the diversity of antibodies. This matches the observed high variability in the variable heavy chain genes.
- **B) Complement activation**: While the complement system plays a role in pathogen clearance, it does not directly contribute to the variability in B cell receptors.
- **C) Class switching recombination**: This process changes the class of antibody produced (e.g., from IgM to IgG) but does not increase variability in the variable regions of the B cell receptor.
- **D) VDJ recombination**: This process generates initial diversity during B cell development in the bone marrow by combining V, D, and J segments. However, it occurs early in B cell maturation and does not explain the observed variability in mature B cells.

The high variability in the variable heavy chain genes observed in the proliferating B cells is best explained by **somatic hypermutation**, a process that occurs after B cell activation and is critical for generating diverse and specific immune responses. 

Answer: A

--- Full Content ---
Okay, so I've got this question about immunology, specifically about rotavirus and the immune response in mice. Hmm, let me try to break this down step by step.

The question says that inner capsid proteins of rotavirus are tagged with GFP and given to mice orally. Then, when they do in vivo imaging, some fluorescence is destroyed by stomach acid and some get entangled in intestinal mucus before reaching secondary lymphoid organs. They then look at the Peyer's patches and isolate the proliferating cells. When they sequence the variable heavy chain genes, they see high variability. What's happening here?

Wait, so Peyer's patches are part of the gut-associated lymphoid tissue (GALT). They're specialized for sampling antigens from the intestinal lumen. So when the rotavirus is given orally, the antigens would be presented to these patches.

The GFP-tagged proteins probably serve as antigens. In the stomach, acid could break down some of these, so not all make it past. Some get stuck in mucus, maybe not reaching the secondary lymphoid organs, but Peyer's patches are still in the intestinal area, so maybe that's where the immune response is initiated.

When they isolate the proliferating cells from the Peyer's patches, these are likely B cells that have been activated by the antigen. The sequencing shows high variability in the variable heavy chain genes. I remember that B cells undergo a process where their variable regions are diversified to create a wide range of antibodies.

Now, let's think about the processes listed in the options:

A) Somatic hypermutation: This occurs in B cells after they've been activated. It's a process where mutations are introduced into the variable regions of the B cell receptor (BCR) genes, increasing the diversity of antibodies. This happens during the later stages of the immune response, especially in the germinal centers.

B) Complement activation: That's part of the innate immune system, helps in opsonization and lytic activity of pathogens, but I don't think this directly causes variability in B cell receptors.

C) Class switching recombination: This is when the B cell changes the class of antibody it produces (like from IgM to IgG), but it doesn't directly increase the variability in the variable regions. It's more about the effector function.

D) VDJ recombination: That's the process during B cell development in the bone marrow where the variable (V), diversity (D), and joining (J) segments are combined to create the initial diversity of the B cell receptors. But this happens early on, during the maturation of B cells, so maybe not what's happening here.

Wait, but the question is about processes happening after the B cells have been activated and are proliferating. So when they're in the germinal centers, they undergo somatic hypermutation, which increases the variability of their receptors. This would explain the high variability in the variable regions they're seeing in the sequencing.

So the process here must be somatic hypermutation. The B cells are diversifying their antibodies to better recognize the rotavirus antigen, which in this case is the GFP-tagged capsid proteins.

Other options: VDJ is during initial B cell development, so not this. Class switching is about changing the isotype, not variable regions. Complement activation is more about innate and maybe phagocytosis or clearing pathogens, not directly about B cell receptor variability.

Therefore, the answer should be A) somatic hypermutation.


The question involves analyzing the immune response to GFP-tagged rotavirus inner capsid proteins administered to mice via oral gavage. The GFP-tagged proteins act as antigens, and some reach the Peyer's patches, where B cells are activated and proliferate. Sequencing the variable heavy chain genes of these proliferating cells reveals high variability, which suggests a process that diversifies the B cell receptors.

To evaluate the options:

- **A) Somatic hypermutation**: This process occurs in activated B cells during the immune response, particularly in germinal centers. It introduces mutations into the variable regions of B cell receptor genes, increasing the diversity of antibodies. This matches the observed high variability in the variable heavy chain genes.
- **B) Complement activation**: While the complement system plays a role in pathogen clearance, it does not directly contribute to the variability in B cell receptors.
- **C) Class switching recombination**: This process changes the class of antibody produced (e.g., from IgM to IgG) but does not increase variability in the variable regions of the B cell receptor.
- **D) VDJ recombination**: This process generates initial diversity during B cell development in the bone marrow by combining V, D, and J segments. However, it occurs early in B cell maturation and does not explain the observed variability in mature B cells.

The high variability in the variable heavy chain genes observed in the proliferating B cells is best explained by **somatic hypermutation**, a process that occurs after B cell activation and is critical for generating diverse and specific immune responses. 

Answer: A